Metraipolis › archive › dc_2f6a353ffa07
Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in… — Europe PMC PMID:41618370
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41618370
- DOI
- 10.1186/s42358-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T10:13:14.248Z
- SHA-256 of the archived text
6d6a01fd865aaaf95841f701e9ed0e2cfa4ed8ec7e37e77cafbbea04beb33a5a- Stable URL of this page
https://metraipolis.com/documento/dc_2f6a353ffa07
How to cite
Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in… — Europe PMC PMID:41618370 — Europe PMC (en), https://europepmc.org/article/MED/41618370 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f6a353ffa07 (Metraipolis archive dc_2f6a353ffa07, sha256 6d6a01fd865aaaf95841f701e9ed0e2cfa4ed8ec7e37e77cafbbea04beb33a5a)
BibTeX
@misc{dc2f6a353ffa07,
title = {Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in… — Europe PMC PMID:41618370},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41618370},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f6a353ffa07; sha256 6d6a01fd865aaaf95841f701e9ed0e2cfa4ed8ec7e37e77cafbbea04beb33a5a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41618370. Agents can read the archived copy with the MCP tool read_document.